Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 352098, 10 pages
http://dx.doi.org/10.1155/2014/352098
Review Article

Management of Poor Responders in IVF: Is There Anything New?

1GENERA, Centre for Reproductive Medicine, Valle Giulia Clinic, Rome, Italy
2Department of Gynecological/Obstetrical Sciences and Reproductive Medicine, University Hospital “G. Martino,” Messina, Italy

Received 24 March 2014; Accepted 26 June 2014; Published 20 July 2014

Academic Editor: Ursula Zollner

Copyright © 2014 Filippo Ubaldi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. P. Polyzos and P. Devroey, “A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel?” Fertility and Sterility, vol. 96, no. 5, pp. 1058.e7–1061.e7, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. S. D. Keay, N. H. Liversedge, R. S. Mathur, and J. M. Jenkins, “Assisted conception following poor ovarian response to gonadotrophin stimulation,” The British Journal of Obstetrics and Gynaecology, vol. 104, no. 5, pp. 521–527, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. Z. Ben-Rafael, D. Bider, U. Dan, M. Zolti, D. Levran, and S. Mashiach, “Combined gonadotropin releasing hormone agonist/human menopausal gonadotropin therapy (GnRH-a/hMG) in normal, high, and poor responders to hMG,” Journal of In Vitro Fertilization and Embryo Transfer, vol. 8, no. 1, pp. 33–36, 1991. View at Publisher · View at Google Scholar · View at Scopus
  4. J. M. Jenkins, D. W. Davies, H. Devonport, F. W. Anthony, S. C. Gadd, and R. H. G. M. Watson Masson, “Comparison of “poor” responders with “good” responders using a standard buserelin/human menopausal gonadotrophin regime for in-vitro fertilization,” Human Reproduction, vol. 6, no. 7, pp. 918–921, 1991. View at Google Scholar · View at Scopus
  5. E. S. Surrey and W. B. Schoolcraft, “Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques,” Fertility and Sterility, vol. 73, no. 4, pp. 667–676, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. E. M. Kolibianakis, C. A. Venetis, K. Diedrich, B. C. Tarlatzis, and G. Griesinger, “Addition of growth hormone to gonadotrophins in ovarian stimulation of poor responders treated by in-vitro fertilization: a systematic review and meta-analysis,” Human Reproduction Update, vol. 15, no. 6, pp. 613–622, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. A. P. Ferraretti, A. La Marca, B. C. J. M. Fauser, B. Tarlatzis, G. Nargund, and L. Gianaroli, “ESHRE consensus on the definition of “poor response” to ovarian stimulation for in vitro fertilization: the Bologna criteria,” Human Reproduction, vol. 26, no. 7, pp. 1616–1624, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. M. J. Faddy, R. G. Gosden, A. Gougeon, S. J. Richardson, and J. F. Nelson, “Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause,” Human Reproduction, vol. 7, no. 10, pp. 1342–1346, 1992. View at Google Scholar · View at Scopus
  9. D. de Ziegler, B. Borghese, and C. Chapron, “Endometriosis and infertility: pathophysiology and management,” The Lancet, vol. 376, no. 9742, pp. 730–738, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Benaglia, E. Somigliana, V. Vighi, G. Ragni, P. Vercellini, and L. Fedele, “Rate of severe ovarian damage following surgery for endometriomas,” Human Reproduction, vol. 25, no. 3, pp. 678–682, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. I. Streuli, D. de Ziegler, V. Gayet et al., “In women with endometriosis anti-Müllerian hormone levels are decreased only in those with previous endometrioma surgery,” Human Reproduction, vol. 27, no. 11, pp. 3294–3303, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Raffi, M. Metwally, and S. Amer, “The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis,” The Journal of Clinical Endocrinology & Metabolism, vol. 97, no. 9, pp. 3146–3154, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. M. de Vos, P. Devroey, and B. C. J. M. Fauser, “Primary ovarian insufficiency,” The Lancet, vol. 376, no. 9744, pp. 911–921, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. M. A. Fritz and L. Speroff, Clinical Gynecologic Endocrinology and Infertility, Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2011.
  15. N. Soto, G. Iñiguez, P. López et al., “Anti-Müllerian hormone and inhibin B levels as markers of premature ovarian aging and transition to menopause in type 1 diabetes mellitus,” Human Reproduction, vol. 24, no. 11, pp. 2838–2844, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. H.-H. Chang, M.-J. Chen, M.-Y. Lu et al., “Iron overload is associated with low anti-müllerian hormone in women with transfusion-dependent β-thalassaemia,” British Journal of Obstetrics and Gynaecology, vol. 118, no. 7, pp. 825–831, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. W. J. K. Hehenkamp, N. A. Volkers, F. J. M. Broekmans et al., “Loss of ovarian reserve after uterine artery embolization: a randomized comparison with hysterectomy,” Human Reproduction, vol. 22, no. 7, pp. 1996–2005, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Tropeano, C. Di Stasi, S. Amoroso, M. R. Gualano, L. Bonomo, and G. Scambia, “Long-term effects of uterine fibroid embolization on ovarian reserve: a prospective cohort study,” Fertility and Sterility, vol. 94, no. 6, pp. 2296–2300, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. Reproductive Endocrinology and Infertility Committee, Family Physicians Advisory Committee, Maternal-Fetal Medicine Committee, Executive and Council of the Society of Obstetricians, K. Liu, and A. Case, “Advanced reproductive age and fertility,” Journal of Obstetrics and Gynaecology Canada: JOGC, vol. 33, no. 11, pp. 1165–1175, 2011. View at Google Scholar · View at Scopus
  20. U. Ulug, I. Ben-Shlomo, E. Turan, H. F. Erden, M. Ali Akman, and M. Bahceci, “Conception rates following assisted reproduction in poor responder patients: a retrospective study in 300 consecutive cycles,” Reproductive BioMedicine Online, vol. 6, no. 4, pp. 439–443, 2003. View at Google Scholar · View at Scopus
  21. X. M. Zhen, J. Qiao, R. Li, L. N. Wang, and P. Liu, “The clinical analysis of poor ovarian response in in-vitro-fertilization embryo-transfer among Chinese couples,” Journal of Assisted Reproduction and Genetics, vol. 25, no. 1, pp. 17–22, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. S. K. Sunkara, J. Tuthill, M. Khairy et al., “Pituitary suppression regimens in poor responders undergoing IVF treatment: a systematic review and meta-analysis,” Reproductive BioMedicine Online, vol. 15, no. 5, article 2938, pp. 539–546, 2007. View at Google Scholar · View at Scopus
  23. T. El-Toukhy, Y. Khalaf, R. Hart, A. Taylor, and P. Braude, “Young age does not protect against the adverse effects of reduced ovarian reserve—an eight year study,” Human Reproduction, vol. 17, no. 6, pp. 1519–1524, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. N. P. Polyzos, M. Nwoye, R. Corona et al., “Live birth rates in Bologna poor responders treated with ovarian stimulation for IVF/ICSI,” Reproductive BioMedicine Online, vol. 28, no. 4, pp. 469–474, 2014. View at Publisher · View at Google Scholar
  25. M. Al-Azemi, S. R. Killick, S. Duffy et al., “Multi-marker assessment of ovarian reserve predicts oocyte yield after ovulation induction,” Human Reproduction, vol. 26, no. 2, pp. 414–422, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. F. J. Broekmans, J. Kwee, D. J. Hendriks, B. W. Mol, and C. B. Lambalk, “A systematic review of tests predicting ovarian reserve and IVF outcome,” Human Reproduction Update, vol. 12, no. 6, pp. 685–718, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. N. A. A. Ebbiary, E. A. Lenton, and I. D. Cooke, “Hypothalamic-pituitary ageing: progressive increase in FSH and LH concentrations throughout the reproductive life in regularly menstruating women,” Clinical Endocrinology, vol. 41, no. 2, pp. 199–206, 1994. View at Publisher · View at Google Scholar · View at Scopus
  28. N. P. Groome, P. J. Illingworth, M. O'Brien et al., “Measurement of dimeric inhibin B throughout the human menstrual cycle,” Journal of Clinical Endocrinology and Metabolism, vol. 81, no. 4, pp. 1401–1405, 1996. View at Publisher · View at Google Scholar · View at Scopus
  29. H. G. Burger, N. Cahir, D. M. Robertson et al., “Serum inhibins A and B fall differentially as FSH rises in perimenopausal women,” Clinical Endocrinology, vol. 48, no. 6, pp. 809–813, 1998. View at Publisher · View at Google Scholar · View at Scopus
  30. C. K. Welt, D. J. McNicholl, A. E. Taylor, and J. E. Hall, “Female reproductive aging is marked by decreased secretion of dimeric inhibin,” The Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 1, pp. 105–111, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. A. La Marca, G. Stabile, A. C. Artenisio, and A. Volpe, “Serum anti-Mullerian hormone throughout the human menstrual cycle,” Human Reproduction, vol. 21, no. 12, pp. 3103–3107, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. A. la Marca, S. Giulini, A. Tirelli et al., “Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology,” Human Reproduction, vol. 22, no. 3, pp. 766–771, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Dólleman, M. J. Faddy, J. van Disseldorp et al., “The relationship between anti-müllerian hormone in women receiving fertility assessments and age at menopause in subfertile women: evidence from large population studies,” Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 5, pp. 1946–1953, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. N. P. Polyzos, S. M. Nelson, D. Stoop et al., “Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization-intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonist? A retrospective single-center study,” Fertility and Sterility, vol. 100, no. 2, pp. 438–444, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. S. L. Broer, M. Dólleman, J. van Disseldorp et al., “Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis,” Fertility and Sterility, vol. 100, no. 2, pp. 420.e7–429.e7, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. J. F. Oudendijk, F. Yarde, M. J. C. Eijkemans, F. J. M. Broekmans, and S. L. Broer, “The poor responder in IVF: Is the prognosis always poor? A systematic review,” Human Reproduction Update, vol. 18, no. 1, Article ID dmr037, pp. 1–11, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. A. M. H. Koning, W. K. H. Kuchenbecker, H. Groen et al., “Economic consequences of overweight and obesity in infertility: a framework for evaluating the costs and outcomes of fertility care,” Human Reproduction Update, vol. 16, no. 3, pp. 246–254, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. J. A. Land, M. I. Yarmolinskaya, J. C. M. Dumoulin, and J. L. H. Evers, “High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome,” Fertility and Sterility, vol. 65, no. 5, pp. 961–965, 1996. View at Google Scholar · View at Scopus
  39. E. S. Surrey, J. Bower, D. M. Hill, J. Ramsey, and M. W. Surrey, “Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization,” Fertility and Sterility, vol. 69, no. 3, pp. 419–424, 1998. View at Publisher · View at Google Scholar · View at Scopus
  40. H. Lashen, W. Ledger, A. Lopez-Bernal, and D. Barlow, “Poor responders to ovulation induction: is proceeding to in-vitro fertilization worthwhile?” Human Reproduction, vol. 14, no. 4, pp. 964–969, 1999. View at Publisher · View at Google Scholar · View at Scopus
  41. B. M. Faber, J. Mayer, B. Cox et al., “Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders,” Fertility and Sterility, vol. 69, no. 5, pp. 826–830, 1998. View at Publisher · View at Google Scholar · View at Scopus
  42. L. Rombauts, A. Suikkari, V. MacLachlan, A. O. Trounson, and D. L. Healy, “Recruitment of follicles by recombinant human follicle-stimulating hormone commencing in the luteal phase of the ovarian cycle,” Fertility and Sterility, vol. 69, no. 4, pp. 665–669, 1998. View at Publisher · View at Google Scholar · View at Scopus
  43. S. R. Lindheim, D. H. Barad, B. Witt, E. Ditkoff, and M. V. Sauer, “Short-term gonadotropin suppression with oral contraceptives benefits poor responders prior to controlled ovarian hyperstimulation,” Journal of Assisted Reproduction and Genetics, vol. 13, no. 9, pp. 745–747, 1996. View at Publisher · View at Google Scholar · View at Scopus
  44. W. Schoolcraft, T. Schlenker, M. Gee, J. Stevens, and L. Wagley, “Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol,” Fertility and Sterility, vol. 67, no. 1, pp. 93–97, 1997. View at Publisher · View at Google Scholar · View at Scopus
  45. Z. H. Z. Ibrahim, P. L. Matson, P. Buck, and B. A. Lieberman, “The use of biosynthetic human growth hormone to augment ovulation induction with buserelin acetate/human menopausal gonadotropin in women with a poor ovarian response,” Fertility and Sterility, vol. 55, no. 1, pp. 202–204, 1991. View at Google Scholar · View at Scopus
  46. S. M. Hughes, Z. H. Huang, I. D. Morris, P. L. Matson, P. Buck, and B. A. Lieberman, “A double-blind cross-over controlled study to evaluate the effect of human biosynthetic growth hormone on ovarian stimulation in previous poor responders to in-vitro fertilization,” Human Reproduction, vol. 9, no. 1, pp. 13–18, 1994. View at Google Scholar · View at Scopus
  47. K. Vishvanath, R. Morris, J. Rinehart, C. Miller, R. Rao, and N. Gleicher, “Limited success using the “flare” protocol in poor responders in cycles with low basal follicle-stimulating hormone levels during in vitro fertilization,” Fertility and Sterility, vol. 67, no. 5, pp. 900–903, 1997. View at Publisher · View at Google Scholar · View at Scopus
  48. T. L. Toth, J. T. Awwad, L. L. Veeck, H. W. Jones Jr., and S. J. Muasher, “Suppression and flare regimens of gonadotropin-releasing hormone agonist: use in women with different basal gonadotropin values in an in vitro fertilization program,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 41, no. 5, pp. 321–326, 1996. View at Google Scholar · View at Scopus
  49. J. S. Younis, “The Bologna criteria for poor ovarian response; has the job been accomplished?” Human Reproduction, vol. 27, no. 6, pp. 1874–1875, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. V. C. Karande, G. S. Jones, L. L. Veeck, and S. J. Muasher, “High-dose follicle-stimulating hormone stimulation at the onset of the menstrual cycle does not improve the in vitro fertilization outcome in low-responder patients,” Fertility and Sterility, vol. 53, no. 3, pp. 486–489, 1990. View at Google Scholar · View at Scopus
  51. M. H. A. van Hooff, A. T. Alberda, G. J. Huisman, G. H. Zeilmaker, and R. A. Leerentveld, “Doubling the human menopausal gonadotrophin dose in the course of an in-vitro fertilization treatment cycle in low responders: a randomized study,” Human Reproduction, vol. 8, no. 3, pp. 369–373, 1993. View at Google Scholar · View at Scopus
  52. G. E. Hofmann, J. P. Toner, S. J. Muasher, and G. S. Jones, “High-dose follicle-stimulating hormone (FSH) ovarian stimulation in low-responder patients for in vitro fertilization,” Journal of in Vitro Fertilization and Embryo Transfer, vol. 6, no. 5, pp. 285–289, 1989. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Berkkanoglu and K. Ozgur, “What is the optimum maximal gonadotropin dosage used in microdose flare-up cycles in poor responders?” Fertility and Sterility, vol. 94, no. 2, pp. 662–665, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. E. G. Hughes, D. M. Fedorkow, S. Daya, M. A. Sagle, P. van de Koppel, and J. A. Collins, “The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials,” Fertility and Sterility, vol. 58, no. 5, pp. 888–896, 1992. View at Google Scholar · View at Scopus
  55. Y. Yoshimura, Y. Nakamura, M. Ando, S. Shiokawa, N. Koyama, and T. Nanno, “Direct effect of gonadotropin-releasing hormone agonists on the rabbit ovarian follicle,” Fertility and Sterility, vol. 57, no. 5, pp. 1091–1097, 1992. View at Google Scholar · View at Scopus
  56. A. Kowalik, L. Barmat, M. Damario, H. Liu, O. Davis, and Z. Rosenwaks, “Ovarian estradiol production in vivo. Inhibitory effect of leuprolide acetate,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 43, no. 5, pp. 413–417, 1998. View at Google Scholar · View at Scopus
  57. S. L. Padilla, K. Dugan, V. Maruschak, S. Shalika, and R. D. Smith, “Use of the flare-up protocol with high dose human follicle stimulating hormone and human menopausal gonadotropins for in vitro fertilization in poor responders,” Fertility and Sterility, vol. 65, no. 4, pp. 796–799, 1996. View at Google Scholar · View at Scopus
  58. V. Karande and N. Gleicher, “A rational approach to the management of low responders in in-vitro fertilization,” Human Reproduction, vol. 14, no. 7, pp. 1744–1748, 1999. View at Publisher · View at Google Scholar · View at Scopus
  59. I. Craft, A. Gorgy, J. Hill, D. Menon, and B. Podsiadly, “Will GnRH antagonists provide new hope for patients considered “difficult responders” to GnRH agonist protocols?” Human Reproduction, vol. 14, no. 12, pp. 2959–2962, 1999. View at Publisher · View at Google Scholar · View at Scopus
  60. M. A. Akman, H. F. Erden, S. B. Tosun, N. Bayazit, E. Aksoy, and M. Bahceci, “Addition of GnRH antagonist in cycles of poor responders undergoing IVF,” Human Reproduction, vol. 15, no. 10, pp. 2145–2147, 2000. View at Publisher · View at Google Scholar · View at Scopus
  61. M. P. Leondires, M. Escalpes, J. H. Segars, R. T. Scott Jr., and B. T. Miller, “Microdose follicular phase gonadotropin-releasing hormone agonists (GnRH-a) compared with luteal phase GnRH-a for ovarian stimulation at in vitro fertilization,” Fertility and Sterility, vol. 72, no. 6, pp. 1018–1023, 1999. View at Publisher · View at Google Scholar · View at Scopus
  62. D. Kyrou, E. M. Kolibianakis, C. A. Venetis, E. G. Papanikolaou, J. Bontis, and B. C. Tarlatzis, “How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis,” Fertility and Sterility, vol. 91, no. 3, pp. 749–766, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. H. Pinkas, R. Orvieto, O. M. Avrech et al., “Gonadotropin stimulation following GnRH-a priming for poor responders in in vitro fertilization—embryo transfer programs,” Gynecological Endocrinology, vol. 14, no. 1, pp. 11–14, 2000. View at Publisher · View at Google Scholar · View at Scopus
  64. M. Schachter, S. Friedler, A. Raziel, D. Strassburger, O. Bern, and R. Ron-El, “Improvement of IVF outcome in poor responders by discontinuation of GnRH analogue during the gonadotropin stimulation phase—a function of improved embryo quality,” Journal of Assisted Reproduction and Genetics, vol. 18, no. 4, pp. 197–204, 2001. View at Google Scholar · View at Scopus
  65. M. Dirnfeld, O. Fruchter, D. Yshai, A. Lissak, A. Ahdut, and H. Abramovici, “Cessation of gonadotropin-releasing hormone analogue (GnRH-a) upon down-regulation versus conventional long GnRH-a protocol in poor responders undergoing in vitro fertilization,” Fertility and Sterility, vol. 72, no. 3, pp. 406–411, 1999. View at Publisher · View at Google Scholar · View at Scopus
  66. J. A. Garcia-Velasco, V. Isaza, A. Requena et al., “High doses of gonadotrophins combined with stop versus non-stop protocol of GnRH analogue administration in low responder IVF patients: a prospective, randomized, controlled trial,” Human Reproduction, vol. 15, no. 11, pp. 2292–2296, 2000. View at Publisher · View at Google Scholar · View at Scopus
  67. H. G. Al-Inany, M. A. Youssef, M. Aboulghar et al., “Gonadotrophin-releasing hormone antagonists for assisted reproductive technology.,” Cochrane Database of Systematic Reviews, no. 5, Article ID CD001750, 2011. View at Google Scholar · View at Scopus
  68. D. Kenigsberg, B. A. Littman, and G. D. Hodgen, “Medical hypophysectomy: I. Dose-response using a gonadotropin-releasing hormone antagonist,” Fertility and Sterility, vol. 42, no. 1, pp. 112–115, 1984. View at Google Scholar · View at Scopus
  69. G. Griesinger, K. Diedrich, B. C. Tarlatzis, and E. M. Kolibianakis, “GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis,” Reproductive BioMedicine Online, vol. 13, no. 5, pp. 628–638, 2006. View at Publisher · View at Google Scholar · View at Scopus
  70. D. Pu, J. Wu, and J. Liu, “Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IVF,” Human Reproduction, vol. 26, no. 10, pp. 2742–2749, 2011. View at Publisher · View at Google Scholar · View at Scopus
  71. G. J. Scheffer, F. J. M. Broekmans, M. Dorland, J. D. F. Habbema, C. W. N. Looman, and E. R. Te Velde, “Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility,” Fertility and Sterility, vol. 72, no. 5, pp. 845–851, 1999. View at Publisher · View at Google Scholar · View at Scopus
  72. L. F. J. M. M. Bancsi, F. J. M. Broekmans, C. W. N. Looman, J. D. F. Habbema, and E. R. te Velde, “Predicting poor ovarian response in IVF: use of repeat basal FSH measurement,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 49, no. 3, pp. 187–194, 2004. View at Google Scholar · View at Scopus
  73. A. van Schanke, S. F. M. van De Wetering-Krebbers, E. Bos, and W. N. Sloot, “Absorption, distribution, metabolism and excretion of corifollitropin alfa, a recombinant hormone with a sustained follicle-stimulating activity,” Pharmacology, vol. 85, no. 2, pp. 77–87, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. N. P. Polyzos, M. Devos, P. Humaidan et al., “Corifollitropin alfa followed by rFSH in a GnRH antagonist protocol for poor ovarian responder patients: an observational pilot study,” Fertility and Sterility, vol. 99, no. 2, pp. 422–426, 2013. View at Publisher · View at Google Scholar · View at Scopus
  75. N. P. Polyzos, M. de Vos, R. Corona et al., “Addition of highly purified HMG after corifollitropin alfa in antagonist-treated poor ovarian responders: a pilot study,” Human Reproduction, vol. 28, no. 5, pp. 1254–1260, 2013. View at Publisher · View at Google Scholar · View at Scopus
  76. M. A. Mahmoud Youssef, M. van Wely, I. Aboulfoutouh, W. El-Khyat, F. van der Veen, and H. Al-Inany, “Is there a place for corifollitropin alfa in IVF/ICSI cycles? A systematic review and meta-analysis,” Fertility and Sterility, vol. 97, no. 4, pp. 876–885, 2012. View at Publisher · View at Google Scholar · View at Scopus
  77. K. A. Reynolds, K. R. Omurtag, P. T. Jimenez, J. S. Rhee, M. G. Tuuli, and E. S. Jungheim, “Cycle cancellation and pregnancy after luteal estradiol priming in women defined as poor responders: a systematic review and meta-analysis,” Human Reproduction, vol. 28, no. 11, pp. 2981–2989, 2013. View at Publisher · View at Google Scholar
  78. R. Fanchin, L. Salomon, A. Castelo-Branco, F. Olivennes, N. Frydman, and R. Frydman, “Luteal estradiol pre-treatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists,” Human Reproduction, vol. 18, no. 12, pp. 2698–2703, 2003. View at Publisher · View at Google Scholar · View at Scopus
  79. N. P. Polyzos and H. Tournaye, “Poor ovarian responders: to meta-analyse or not, that is the question,” Human Reproduction, vol. 29, pp. 634–635, 2014. View at Google Scholar
  80. M. J. Hill, E. D. Levens, G. Levy et al., “The use of recombinant luteinizing hormone in patients undergoing assisted reproductive techniques with advanced reproductive age: a systematic review and meta-analysis,” Fertility and Sterility, vol. 97, no. 5, pp. 1108.el–1114.e1, 2012. View at Publisher · View at Google Scholar · View at Scopus
  81. J. K. Bosdou, C. A. Venetis, E. M. Kolibianakis et al., “The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis,” Human Reproduction Update, vol. 18, no. 2, pp. 127–145, 2012. View at Publisher · View at Google Scholar · View at Scopus
  82. W. Fan, S. Li, Q. Chen, Z. Huang, Q. Ma, and Y. Wang, “Recombinant Luteinizing Hormone supplementation in poor responders undergoing IVF: a systematic review and meta-analysis,” Gynecological Endocrinology, vol. 29, no. 4, pp. 278–284, 2013. View at Publisher · View at Google Scholar · View at Scopus
  83. P. Lehert, E. M. Kolibianakis, C. A. Venetis et al., “Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis,” Reproductive Biology and Endocrinology, vol. 12, article 17, 2014. View at Publisher · View at Google Scholar
  84. J. B. Davoren, B. G. Kasson, C. H. Li, and A. J. W. Hsueh, “Specific insulin-like growth factor (IGF) I- and II-binding sites on rat granulosa cells: relation to IGF action,” Endocrinology, vol. 119, no. 5, pp. 2155–2162, 1986. View at Publisher · View at Google Scholar · View at Scopus
  85. C. J. Hsu and J. M. Hammond, “Concomitant effects of growth hormone on secretion of insulin-like growth factor I and progesterone by cultured porcine granulosa cells,” Endocrinology, vol. 121, no. 4, pp. 1343–1348, 1987. View at Publisher · View at Google Scholar · View at Scopus
  86. A. Barreca, P. G. Artini, P. Del Monte et al., “In vivo and in vitro effect of growth hormone on estradiol secretion by human granulosa cells,” Journal of Clinical Endocrinology and Metabolism, vol. 77, no. 1, pp. 61–67, 1993. View at Publisher · View at Google Scholar · View at Scopus
  87. E. Y. Adashi, C. E. Resnick, A. J. D'Ercole, M. E. Svoboda, and J. J. Van Wyk, “Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function.,” Endocrine Reviews, vol. 6, no. 3, pp. 400–420, 1985. View at Publisher · View at Google Scholar · View at Scopus
  88. X.-C. Jia, J. Kalmijn, and A. J. W. Hsueh, “Growth hormone enhances follicle-stimulating hormone-induced differentiation of cultured rat granulosa cells,” Endocrinology, vol. 118, no. 4, pp. 1401–1409, 1986. View at Publisher · View at Google Scholar · View at Scopus
  89. J. Dor, D. S. Seidman, E. Amudal, D. Bider, D. Levran, and S. Mashiach, “Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double-blind study,” Human Reproduction, vol. 10, no. 1, pp. 40–43, 1995. View at Publisher · View at Google Scholar · View at Scopus
  90. M. Eftekhar, A. Aflatoonian, F. Mohammadian, and T. Eftekhar, “Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology,” Archives of Gynecology and Obstetrics, vol. 287, no. 5, pp. 1017–1021, 2013. View at Publisher · View at Google Scholar · View at Scopus
  91. K. J. Ryan, Z. Petro, and J. Kaiser, “Steroid formation by isolated and recombined ovarian granulosa and tehcal cells,” The Journal of Clinical Endocrinology & Metabolism, vol. 28, no. 3, pp. 355–358, 1968. View at Publisher · View at Google Scholar · View at Scopus
  92. S. J. Weil, K. Vendola, J. Zhou et al., “Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations,” Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 7, pp. 2479–2485, 1998. View at Publisher · View at Google Scholar · View at Scopus
  93. K. A. Vendola, J. Zhou, O. O. Adesanya, S. J. Weil, and C. A. Bondy, “Androgens stimulate early stages of follicular growth in the primate ovary,” Journal of Clinical Investigation, vol. 101, no. 12, pp. 2622–2629, 1998. View at Publisher · View at Google Scholar · View at Scopus
  94. J. L. Frattarelli and E. H. Peterson, “Effect of androgen levels on in vitro fertilization cycles,” Fertility and Sterility, vol. 81, no. 6, pp. 1713–1714, 2004. View at Publisher · View at Google Scholar · View at Scopus
  95. P. R. Casson, N. Santoro, K. Elkind-Hirsch et al., “Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six- month trial,” Fertility and Sterility, vol. 70, no. 1, pp. 107–110, 1998. View at Publisher · View at Google Scholar · View at Scopus
  96. S. K. Sunkara and A. Coomarasamy, “Androgen pretreatment in poor responders undergoing controlled ovarian stimulation and in vitro fertilization treatment,” Fertility and Sterility, vol. 95, no. 8, pp. e73–e75, 2011. View at Publisher · View at Google Scholar · View at Scopus
  97. S. K. Sunkara, A. Coomarasamy, W. Arlt, and S. Bhattacharya, “Should androgen supplementation be used for poor ovarian response in IVF?” Human Reproduction, vol. 27, no. 3, pp. 637–640, 2012. View at Publisher · View at Google Scholar · View at Scopus
  98. Z. Weiner, I. Thaler, J. Levron, N. Lewit, and J. Itskovitz-Eldor, “Assessment of ovarian and uterine blood flow by transvaginal color Doppler in ovarian-stimulated women: correlation with the number of follicles and steroid hormone levels,” Fertility and Sterility, vol. 59, no. 4, pp. 743–749, 1993. View at Google Scholar · View at Scopus
  99. S. Bassil, C. Wyns, D. Toussaint-Demylle, M. Nisolle, S. Gordts, and J. Donnez, “The relationship between ovarian vascularity and the duration of stimulation in in-vitro fertilization,” Human Reproduction, vol. 12, no. 6, pp. 1240–1245, 1997. View at Publisher · View at Google Scholar · View at Scopus
  100. A. Pellicer, M. J. Ballester, M. D. Serrano et al., “Aetiological factors involved in the low response to gonadotrophins in infertile women with normal basal serum follicle stimulating hormone levels,” Human Reproduction, vol. 9, no. 5, pp. 806–811, 1994. View at Google Scholar · View at Scopus
  101. C. Battaglia, A. D. Genazzani, G. Regnani, M. R. Primavera, F. Petraglia, and A. Volpe, “Perifollicular Doppler flow and follicular fluid vascular endothelial growth factor concentrations in poor responders,” Fertility and Sterility, vol. 74, no. 4, pp. 809–812, 2000. View at Publisher · View at Google Scholar · View at Scopus
  102. M. Rubinstein, A. Marazzi, and E. Polak de Fried, “Low-dose aspirin treatment improves ovarian responsiveness, uterine and ovarian blood flow velocity, implantation, and pregnancy rates in patients undergoing in vitro fertilization: a prospective, randomized, double-blind placebo-controlled assay,” Fertility and Sterility, vol. 71, no. 5, pp. 825–829, 1999. View at Publisher · View at Google Scholar · View at Scopus
  103. L. G. Nardo, I. Granne, and J. Stewart, “Medical adjuncts in IVF: evidence for clinical practice,” Human Fertility, vol. 12, no. 1, pp. 1–13, 2009. View at Publisher · View at Google Scholar · View at Scopus
  104. U. Waldenström, D. Hellberg, and S. Nilsson, “Low-dose aspirin in a short regimen as standard treatment in in vitro fertilization: a randomized, prospective study,” Fertility and Sterility, vol. 81, no. 6, pp. 1560–1564, 2004. View at Publisher · View at Google Scholar · View at Scopus
  105. J. L. Frattarelli, G. D. E. McWilliams, M. J. Hill, K. A. Miller, and R. T. Scott Jr., “Low-dose aspirin use does not improve in vitro fertilization outcomes in poor responders,” Fertility and Sterility, vol. 89, no. 5, pp. 1113–1117, 2008. View at Publisher · View at Google Scholar · View at Scopus
  106. B. Urman, K. Yakin, and B. Balaban, “Recurrent implantation failure in assisted reproduction: How to counsel and manage. B. Treatment options that have not been proven to benefit the couple,” Reproductive BioMedicine Online, vol. 11, no. 3, pp. 382–391, 2005. View at Google Scholar · View at Scopus
  107. B. S. Hurst, J. T. Bhojwani, P. B. Marshburn, M. A. Papadakis, T. A. Loeb, and M. L. Matthews, “Low-dose aspirin does not improve ovarian stimulation, endometrial response, or pregnancy rates for in vitro fertilization,” Journal of Experimental and Clinical Assisted Reproduction, vol. 2, no. 8, 2005. View at Publisher · View at Google Scholar · View at Scopus
  108. A. Revelli, E. Dolfin, G. Gennarelli et al., “Low-dose acetylsalicylic acid plus prednisolone as an adjuvant treatment in IVF: a prospective, randomized study,” Fertility and Sterility, vol. 90, no. 5, pp. 1685–1691, 2008. View at Publisher · View at Google Scholar · View at Scopus
  109. T. A. Gelbaya, M. Kyrgiou, T. C. Li, C. Stern, and L. G. Nardo, “Low-dose aspirin for in vitro fertilization: a systematic review and meta-analysis,” Human Reproduction Update, vol. 13, no. 4, pp. 357–364, 2007. View at Publisher · View at Google Scholar · View at Scopus
  110. F. M. Ubaldi, L. Rienzi, S. Ferrero et al., “Management of poor responders in IVF,” Reproductive BioMedicine Online, vol. 10, no. 2, pp. 235–246, 2005. View at Publisher · View at Google Scholar · View at Scopus
  111. F. M. Ubaldi, L. Rienzi, E. Baroni et al., “Hopes and facts about mild ovarian stimulation,” Reproductive BioMedicine Online, vol. 14, no. 6, pp. 675–681, 2007. View at Google Scholar · View at Scopus
  112. M. Schimberni, F. Morgia, J. Colabianchi et al., “Natural-cycle in vitro fertilization in poor responder patients: a survey of 500 consecutive cycles,” Fertility and Sterility, vol. 92, no. 4, pp. 1297–1301, 2009. View at Publisher · View at Google Scholar · View at Scopus
  113. N. P. Polyzos, C. Blockeel, W. Verpoest et al., “Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria,” Human Reproduction, vol. 27, no. 12, pp. 3481–3486, 2012. View at Publisher · View at Google Scholar · View at Scopus
  114. F. Ubaldi, R. Anniballo, S. Romano et al., “Cumulative ongoing pregnancy rate achieved with oocyte vitrification and cleavage stage transfer without embryo selection in a standard infertility program,” Human Reproduction, vol. 25, no. 5, pp. 1199–1205, 2010. View at Publisher · View at Google Scholar · View at Scopus
  115. Practice Committees of American Society for Reproductive Medicine and Society for Assisted Reproductive Technology, “Mature oocyte cryopreservation: a guideline,” Fertility and Sterility, vol. 99, pp. 37–43, 2013. View at Google Scholar
  116. A. Cobo, N. Garrido, J. Crespo, R. José, and A. Pellicer, “Accumulation of oocytes: a new strategy for managing low-responder patients,” Reproductive BioMedicine Online, vol. 24, no. 4, pp. 424–432, 2012. View at Publisher · View at Google Scholar · View at Scopus
  117. N. Noyes, E. Porcu, and A. Borini, “Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies,” Reproductive BioMedicine Online, vol. 18, no. 6, pp. 769–776, 2009. View at Publisher · View at Google Scholar · View at Scopus
  118. L. Rienzi, A. Cobo, A. Paffoni et al., “Consistent and predictable delivery rates after oocyte vitrification: an observational longitudinal cohort multicentric study,” Human Reproduction, vol. 27, no. 6, pp. 1606–1612, 2012. View at Publisher · View at Google Scholar · View at Scopus